Quarter of a million on offer to breakthrough in toxicology research


- Last updated on GMT

Related tags Research

Cosmetics company Lush is offering a quarter of a million pound prize to try and encourage researchers to deliver a breakthrough in toxicology research that could ultimately lead to the replacement of animals used in product safety testing.

The 'Black Box' prize of £250,000 (€293,000) hopes to stimulate an international research focus on describing human toxicology pathways and the development of assays and computational tools to identify whether or not chemicals trigger these pathways and cause adverse effects.


Following the cosmetics ban in Europe back in March this year, the hope is that this will see the development of breakthrough alternatives that can also be used in other industries too.

Lush’s business model is well-known for its animal-free testing ethos and the Prize was conceived, in partnership with the Ethical Consumer Research Association, as a pragmatic endeavour to encourage the delivery of alternatives to animal models, when it was introduced last year.

If the prize is not awarded in any one year, the £250k is split equally across several categories - including Science, Young Researcher and Training awards - to reward innovative scientists and initiatives that are working towards the replacement of animal testing.


Dr Kelly BéruBé, director of the Lung & Particle Research Group at Cardiff University’s School of Bioscience is one of the judges, and says she is excited to see the developments that are submitted.

“To me there’s no doubt that generating more robust and relevant research results based on knowledge of human toxicology pathways could have significant impact on the speed and cost of translating basic research into patient benefit,”​ says the internationally renowned scientist.

“The research community has got stuck in a rut of using a test model that we know doesn’t really fit the bill at all – and that the public is generally uncomfortable with us using - because regulatory bodies insist on using animals. I think it’s time to develop innovative solutions to these challenges that can really help to change this culture.”


The £250k Prize will be offered to a research team that fully elucidates and describes a human toxicity pathway, with experimental evidence to demonstrate all the links in the pathway from the first interaction of one or more chemical molecules to the full effects at the cellular level.

“Whilst a full elucidation of some toxicity pathways is close – for example for direct carcinogens and for skin sensitising chemicals, the Black Box award is likely to need a large collaborative effort, involving a raft of new and emerging models and techniques that bring together components to answer different aspects of one question,”​ says Dr BéruBé.

“It’s a tough ask, and that’s reflected in the size of the Prize, which is a serious amount of money.”

Related news

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers